本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Galmed Pharmaceuticals Ltd.

1.25
-0.0300-2.34%
盘后1.21-0.0400-3.20%19:56 EDT
成交量:45.46万
成交额:55.78万
市值:282.25万
市盈率:-0.15
高:1.30
开:1.30
低:1.15
收:1.28
数据加载中...
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/05

非美公司披露报告

2018/10/29

员工持股计划

2018/10/16

非美公司披露报告